Omeros (OMER) Deferred Taxes (2012 - 2020)

Omeros (OMER) posted Deferred Taxes of -$2.3 million for Q4 2020, down 2737.93% sequentially from $87000.0 in Q1 2013.

Analysis

Omeros (OMER) Deferred Taxes (2012 - 2020) Analysis & Trends

Omeros has reported Deferred Taxes for 3 years, with the latest figure at -$2.3 million in Q4 2020.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Vertex Pharmaceuticals	138.47 Bn	130.62 Bn	2.84 Bn	-69.70 Mn
2	Regeneron Pharmaceuticals	85.18 Bn	77.19 Bn	3.93 Bn	194.40 Mn
3	Argenx Se	63.38 Bn	58.19 Bn	1.37 Bn	-
4	Moderna	58.09 Bn	52.95 Bn	52.00 Mn	-
5	Revolution Medicines	44.33 Bn	44.33 Bn	-	-
6	BeOne Medicines	40.02 Bn	34.92 Bn	1.53 Bn	-
7	Alnylam Pharmaceuticals	35.57 Bn	32.27 Bn	992.69 Mn	2.66 Mn
8	Royalty Pharma	28.45 Bn	27.61 Bn	-	-
9	Insmed	27.48 Bn	26.32 Bn	358.27 Mn	-
10	Omeros	1.38 Bn	1.38 Bn	27.73 Mn	-

Historic Data

Download Data